Loading...

Home
ETF
GLSI

GLSI

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

GLSI News

Valuation Analysis of U.S. Small-Cap Healthcare Stocks

Jun 02 2026seekingalpha

Greenwich LifeSciences Reports Positive Phase 3 Data for Breast Cancer Vaccine

Jun 01 2026NASDAQ.COM

Greenwich LifeSciences Updates Financial Status Amid Nasdaq Filing Delay

Jun 01 2026stocktwits

Greenwich LifeSciences Updates on 10-K Filing

Jun 01 2026Newsfilter

Greenwich LifeSciences Receives Nasdaq Notification on Compliance

May 22 2026seekingalpha

Greenwich LifeSciences Receives Nasdaq Notification Regarding 10-K Filing

Apr 22 2026seekingalpha

Greenwich LifeSciences Expands Vaccine Trial to Broader Patient Population

Apr 20 2026stocktwits

Greenwich LifeSciences Presents Significant Data from GLSI-100 Phase III Trial

Apr 20 2026NASDAQ.COM

Greenwich LifeSciences Updates Financing Strategy Amid Phase III Trial Progress

Apr 14 2026Newsfilter

Greenwich LifeSciences Updates Patent Claims for GLSI-100

Apr 07 2026Newsfilter

Greenwich LifeSciences Reports Promising Phase 3 Trial Data for GLSI-100

Mar 17 2026NASDAQ.COM

Greenwich LifeSciences Shares Surge 13% on Positive Immunotherapy Trial Results

Mar 17 2026stocktwits

Greenwich LifeSciences Updates on FLAMINGO-01 Trial Progress

Mar 17 2026Yahoo Finance

Greenwich LifeSciences Accelerates Clinical Trial Screening Rate

Mar 03 2026NASDAQ.COM

Greenwich LifeSciences Updates on Clinical Trial Progress

Mar 03 2026Newsfilter

Greenwich LifeSciences Announces AACR Abstracts for FLAMINGO-01

Feb 24 2026Newsfilter